Cargando…
Peanut anaphylaxis in 2022: Decoupling epinephrine usage from emergency department evaluation
Autores principales: | Winslow, Andrew, Gilmore, Alexander, Kim, Edwin H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212777/ https://www.ncbi.nlm.nih.gov/pubmed/35718283 http://dx.doi.org/10.1016/j.anai.2022.06.007 |
Ejemplares similares
-
Epinephrine in anaphylaxis
por: Morriello, Florence, et al.
Publicado: (2023) -
Underuse of Epinephrine for Pediatric Anaphylaxis Victims in the Emergency Department: A Population-based Study
por: Choi, Yoo Jin, et al.
Publicado: (2019) -
Investigation of the underuse of adrenaline (epinephrine) and prognosis among patients with anaphylaxis at emergency department admission
por: Lin, Yen-Yue, et al.
Publicado: (2023) -
Limited effect of intramuscular epinephrine on cardiovascular parameters during peanut-induced anaphylaxis: An observational cohort study
por: Turner, Paul J., et al.
Publicado: (2021) -
Epinephrine Administered in Anaphylaxis: The Evolution of 0.3 mg Dosage
por: Coady, Peyton, et al.
Publicado: (2023)